2006
DOI: 10.1016/j.ijantimicag.2005.11.002
|View full text |Cite
|
Sign up to set email alerts
|

Clinical consequences of resistant Candida infections in intensive care

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
7
0

Year Published

2007
2007
2019
2019

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 15 publications
(7 citation statements)
references
References 49 publications
0
7
0
Order By: Relevance
“…Candida albicans is one of the leading opportunistic fungal pathogens, which still causes serious mucosal and systemic infections among immunocompromised patients, including AIDS patients and patients undergoing transplantation or anticancer chemotherapy. Despite the severity of candidosis and reduced treatment possibilities emerging due to a rising number of resistant strains (Montravers & Jabbour, 2006), little is known about the virulence determinants of C. albicans or its interactions with the host organism. However, medical importance is by far not the only reason for a detailed investigation of C. albicans biology.…”
Section: Discussionmentioning
confidence: 99%
“…Candida albicans is one of the leading opportunistic fungal pathogens, which still causes serious mucosal and systemic infections among immunocompromised patients, including AIDS patients and patients undergoing transplantation or anticancer chemotherapy. Despite the severity of candidosis and reduced treatment possibilities emerging due to a rising number of resistant strains (Montravers & Jabbour, 2006), little is known about the virulence determinants of C. albicans or its interactions with the host organism. However, medical importance is by far not the only reason for a detailed investigation of C. albicans biology.…”
Section: Discussionmentioning
confidence: 99%
“…[8] However, prolonged use of azoles has led to the development of drug resistance in C. albicans and other species. [6913] Among the factors contributing to development of resistance to azoles, the selection of intrinsically less susceptible organisms, such as C. glabrata and Candida krusei , and the acquisition of resistance by previously susceptible strains of C. albicans following long-term azoles exposure have been documented. [1213] To manage the patients with candidiasis, antifungal susceptibility testing has become an important step in guiding physicians in the selection of proper antifungal therapy.…”
Section: Introductionmentioning
confidence: 99%
“…The number of antifungal families available and their use in therapy is very limited (1)(2)(3)(4). Recently, a new family of specific fungal cell wall synthesis inhibitors has emerged as an alternative antifungal therapy and is gaining increasing relevance yearly (5)(6)(7).…”
mentioning
confidence: 99%